Breaking News Instant updates and real-time market news.

LGND

Ligand

$108.10 /

+1.88 (+1.77%)

15:23
12/21/16
12/21
15:23
12/21/16
15:23

Ligand accused of unethical behavior in letter sent to U.S. Senate

In a letter to U.S. Senate Special Committee on Aging members Susan Collins and Claire McCaskill, The Lantern Foundation's Emmanuel Lemelson commended them for "uncovering unethical and sometimes criminal behavior on the part of unethical pharmaceutical companies" and claimed Ligand is "the industry's most significant abuser of these standards and laws." According to Lemelson: "These include multiple abuses and violations of existing pharmaceutical classification, reimbursement, and accounting statutes and standards by Ligand. In particular, Ligand Pharmaceuticals' so called "licensing" model is a nexus for a new breed of unethical pharmaceutical companies whose primary goal is to reap extraordinary profits on the backs of patients, taxpayers and shareholders by abusing the Orphan Drug Act of 1983 as well as a litany of accounting loopholes."

  • 21

    Dec

LGND Ligand
$108.10 /

+1.88 (+1.77%)

11/07/16 Stephens
Ligand price target lowered to $125 from $150 at Stephens
10/10/16 Roth Capital
Ligand price target raised to $154 after Carnexiv approval at Roth Capital
10/05/16 H.C. Wainwright
Ligand price target raised to $160 from $146 at H.C. Wainwright
09/07/16
On The Fly: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Periodicals
Disney World opens gates as COVID numbers rise, NY Times » 18:05
07/12/20
07/12
18:05
07/12/20
18:05
DIS

Disney

$119.33 /

+2.42 (+2.07%)

After closing in March…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

07/10/20 JPMorgan
JPMorgan has 'increasing conviction' in Disney returning to health
07/08/20 Guggenheim
Disney price target raised to $123 from $115 at Guggenheim
06/24/20 Morgan Stanley
Morgan Stanley says time might be right for Disney to move ESPN to streaming
06/19/20 Wells Fargo
Disney price target raised to $118 from $107 at Wells Fargo
DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

Periodicals
Tesla shaves $3,000 off Model Y price, Bloomberg reports » 17:58
07/12/20
07/12
17:58
07/12/20
17:58
TSLA

Tesla

$1,547.54 /

+153.99 (+11.05%)

Tesla has cut the price…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

07/09/20 Wedbush
China growth story worth $400/share in a bull case to Tesla, says Wedbush
07/07/20 Morgan Stanley
Morgan Stanley raises Tesla price target to $740 with new bull case of $2,070
07/07/20 Barclays
Tesla bears should 'remain in the shelter,' says Barclays
07/06/20 JMP Securities
Tesla price target raised to $1,500 from $1,050 at JMP Securities
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

  • 14
    Feb
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

Periodicals
Chairman says WeWork set to have positive cash flow in 2021, FT reports » 17:53
07/12/20
07/12
17:53
07/12/20
17:53
WE

We Company

$0.00 /

+ (+0.00%)

, SFTBY

SoftBank

$0.00 /

+ (+0.00%)

WeWork (WE) is on track…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WE We Company
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

WE We Company
$0.00 /

+ (+0.00%)

10/25/19 Jefferies
SoftBank downgraded to Hold from Buy at Jefferies
09/10/19
We Company IPO is 'full speed ahead,' CNBC reports
SFTBY SoftBank
$0.00 /

+ (+0.00%)

07/10/20 Nomura Instinet
SoftBank price target raised to 7,240 yen from 6,640 yen at Nomura Instinet
05/26/20 Citi
SoftBank price target lowered to 7,100 yen from 8,200 yen at Citi
03/24/20 Jefferies
SoftBank upgraded to Buy from Hold at Jefferies
02/13/20 HSBC
SoftBank price target raised to 7,000 yen after Sprint deal approval
WE We Company
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

Periodicals
Credit Suisse could cut 'hundreds' of jobs, Bloomberg reports » 17:27
07/12/20
07/12
17:27
07/12/20
17:27
CS

Credit Suisse

$10.58 /

+0.34 (+3.32%)

Credit Suisse could cut…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.58 /

+0.34 (+3.32%)

CS Credit Suisse
$10.58 /

+0.34 (+3.32%)

07/09/20 JPMorgan
Credit Suisse price target raised to CHF 11.80 from CHF 11 at JPMorgan
07/08/20 Morgan Stanley
Credit Suisse price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/07/20 UBS
Credit Suisse downgraded to Neutral from Buy at UBS
06/26/20 Deutsche Bank
Credit Suisse named short-term investment idea at Deutsche Bank
CS Credit Suisse
$10.58 /

+0.34 (+3.32%)

CS Credit Suisse
$10.58 /

+0.34 (+3.32%)

CS Credit Suisse
$10.58 /

+0.34 (+3.32%)

CS Credit Suisse
$10.58 /

+0.34 (+3.32%)

Periodicals
OPEC, Russia may ease oil production cuts, NY Times reports » 17:24
07/12/20
07/12
17:24
07/12/20
17:24
BP

BP

$22.46 /

+0.405 (+1.84%)

, COP

ConocoPhillips

$39.70 /

+1.4 (+3.66%)

, TOT

Total

$37.77 /

+0.59 (+1.59%)

, XOM

Exxon Mobil

$42.66 /

+1.315 (+3.18%)

, CVX

Chevron

$85.24 /

+2.46 (+2.97%)

, RDS.A

Royal Dutch Shell

$32.20 /

+0.91 (+2.91%)

Saudi Arabia, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BP BP
$22.46 /

+0.405 (+1.84%)

COP ConocoPhillips
$39.70 /

+1.4 (+3.66%)

TOT Total
$37.77 /

+0.59 (+1.59%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

CVX Chevron
$85.24 /

+2.46 (+2.97%)

RDS.A Royal Dutch Shell
$32.20 /

+0.91 (+2.91%)

BP BP
$22.46 /

+0.405 (+1.84%)

07/01/20 Barclays
BP price target raised to 400 GBp from 380 GBp at Barclays
07/01/20 JPMorgan
BP price target lowered to 400 GBp from 425 GBp at JPMorgan
06/17/20 UBS
BP price target lowered to 370 GBp from 400 GBp at UBS
06/15/20 UBS
BP price target lowered to 400 GBp from 410 GBp at UBS
COP ConocoPhillips
$39.70 /

+1.4 (+3.66%)

06/19/20 Mizuho
ConocoPhillips price target raised to $46 from $37 at Mizuho
06/12/20 Jefferies
Jefferies reinstates ConocoPhillips at Buy with $56 price target
06/12/20 Jefferies
ConocoPhillips reinstated with a Buy at Jefferies
05/21/20 Mizuho
ConocoPhillips price target raised to $37 from $33 at Mizuho
TOT Total
$37.77 /

+0.59 (+1.59%)

06/15/20 UBS
Total price target lowered to EUR 44 from EUR 45 at UBS
06/02/20 Wolfe Research
Total downgraded to Peer Perform from Outperform at Wolfe Research
05/15/20 JPMorgan
JPMorgan replaces BP with Total on European Analyst Focus List
05/13/20 Redburn
Total upgraded to Buy from Neutral at Redburn
XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
05/13/20 Redburn
Exxon Mobil upgraded to Neutral from Sell at Redburn
05/04/20 Credit Suisse
Exxon Mobil price target raised to $45 from $37 at Credit Suisse
CVX Chevron
$85.24 /

+2.46 (+2.97%)

06/10/20
Fly Intel: Top five analyst downgrades
06/10/20
Chevron cut to Underperform at RBC Capital on valuation
06/10/20 RBC Capital
Chevron downgraded to Underperform from Sector Perform at RBC Capital
06/09/20
BofA moves 'up the risk curve' in oil, upgrades Occidental, downgrades Chevron
RDS.A Royal Dutch Shell
$32.20 /

+0.91 (+2.91%)

06/15/20 UBS
Royal Dutch Shell price target raised to 1,750 GBp from 1,650 GBp at UBS
05/13/20 Redburn
Royal Dutch Shell upgraded to Neutral from Sell at Redburn
05/04/20 UBS
Royal Dutch Shell price target lowered to 1,700 GBp from 1,800 GBp at UBS
05/01/20 Citi
Citi cuts Royal Dutch Shell price target 11% to GBp 1180
BP BP
$22.46 /

+0.405 (+1.84%)

COP ConocoPhillips
$39.70 /

+1.4 (+3.66%)

TOT Total
$37.77 /

+0.59 (+1.59%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

CVX Chevron
$85.24 /

+2.46 (+2.97%)

RDS.A Royal Dutch Shell
$32.20 /

+0.91 (+2.91%)

BP BP
$22.46 /

+0.405 (+1.84%)

COP ConocoPhillips
$39.70 /

+1.4 (+3.66%)

TOT Total
$37.77 /

+0.59 (+1.59%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

CVX Chevron
$85.24 /

+2.46 (+2.97%)

RDS.A Royal Dutch Shell
$32.20 /

+0.91 (+2.91%)

BP BP
$22.46 /

+0.405 (+1.84%)

COP ConocoPhillips
$39.70 /

+1.4 (+3.66%)

TOT Total
$37.77 /

+0.59 (+1.59%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

CVX Chevron
$85.24 /

+2.46 (+2.97%)

RDS.A Royal Dutch Shell
$32.20 /

+0.91 (+2.91%)

BP BP
$22.46 /

+0.405 (+1.84%)

COP ConocoPhillips
$39.70 /

+1.4 (+3.66%)

TOT Total
$37.77 /

+0.59 (+1.59%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

CVX Chevron
$85.24 /

+2.46 (+2.97%)

Periodicals
Ubisoft probing harassment allegations as executives step down, WSJ reports » 17:19
07/12/20
07/12
17:19
07/12/20
17:19
UBSFY

Ubisoft

$0.00 /

+ (+0.00%)

Ubisoft said two more…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

07/08/20 Morgan Stanley
Ubisoft price target raised to EUR 90 from EUR 80 at Morgan Stanley
07/07/20 Barclays
Ubisoft price target raised to EUR 76 from EUR 66 at Barclays
06/16/20 Stifel
Ubisoft initiated with a Buy at Stifel
05/19/20 Berenberg
Ubisoft price target lowered to EUR 80 from EUR 81 at Berenberg
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

Periodicals
ESPN suspends high-profile NBA reporter after profane email to Senator, WSJ says » 17:12
07/12/20
07/12
17:12
07/12/20
17:12
DIS

Disney

$119.33 /

+2.42 (+2.07%)

Walt Disney's ESPN…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

07/10/20 JPMorgan
JPMorgan has 'increasing conviction' in Disney returning to health
07/08/20 Guggenheim
Disney price target raised to $123 from $115 at Guggenheim
06/24/20 Morgan Stanley
Morgan Stanley says time might be right for Disney to move ESPN to streaming
06/19/20 Wells Fargo
Disney price target raised to $118 from $107 at Wells Fargo
DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

DIS Disney
$119.33 /

+2.42 (+2.07%)

Hot Stocks
Spark announces updated data on SPK-8011 from Phase 1/2 trial in Hemophilia A » 16:51
07/12/20
07/12
16:51
07/12/20
16:51
RHHBY

Roche

$0.00 /

+ (+0.00%)

Spark Therapeutics, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Amag Pharmaceuticals announces presentation of ciraparantag data » 16:46
07/12/20
07/12
16:46
07/12/20
16:46
AMAG

Amag Pharmaceuticals

$7.27 /

+0.21 (+2.97%)

Amag Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMAG Amag Pharmaceuticals
$7.27 /

+0.21 (+2.97%)

AMAG Amag Pharmaceuticals
$7.27 /

+0.21 (+2.97%)

05/12/20 H.C. Wainwright
Amag Pharmaceuticals price target raised to $10 from $9 at H.C. Wainwright
05/11/20 Piper Sandler
Amag shares to continue to see pressure from headwinds, says Piper Sandler
04/17/20 H.C. Wainwright
Amag Pharmaceuticals price target lowered to $9 from $12 at H.C. Wainwright
03/04/20 Piper Sandler
Amag Pharmaceuticals price target lowered to $7 from $9 at Piper Sandler
AMAG Amag Pharmaceuticals
$7.27 /

+0.21 (+2.97%)

Hot Stocks
Takeda provides updates on Pharmacokinetic-guided Prophylaxis studies » 16:24
07/12/20
07/12
16:24
07/12/20
16:24
TAK

Takeda Pharmaceutical

$17.26 /

-0.02 (-0.12%)

Takeda Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.26 /

-0.02 (-0.12%)

TAK Takeda Pharmaceutical
$17.26 /

-0.02 (-0.12%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TAK Takeda Pharmaceutical
$17.26 /

-0.02 (-0.12%)

TAK Takeda Pharmaceutical
$17.26 /

-0.02 (-0.12%)

TAK Takeda Pharmaceutical
$17.26 /

-0.02 (-0.12%)

Hot Stocks
Gilat to file counterclaims seeking merger enforcement, monetary damages payment » 16:14
07/12/20
07/12
16:14
07/12/20
16:14
GILT

Gilat Satellite

$5.10 /

-0.01 (-0.20%)

Gilat Satellite announced…

Gilat Satellite announced that further to its announcement of July 8, 2020, it was notified on July 11, 2020 that an amended complaint was filed by Comtech Telecommunications and its subsidiary, Convoy, against Gilat in the Court of Chancery of the State of Delaware. The amended complaint seeks an additional declaratory judgment that Gilat has suffered a "Material Adverse Effect" as defined in the Merger Agreement, as a result of the COVID-19 pandemic and, as a consequence, Comtech is not required to consummate the merger because certain closing conditions of the Merger Agreement cannot be satisfied. Gilat said it strongly rejects all such allegations and believes that no Material Adverse Effect under the Merger Agreement has occurred and that Comtech's complaint is nothing more than an effort to avoid its clear contractual obligation to acquire Gilat, due to Comtech's own rapidly deteriorating performance. "Comtech's continuous willful breaches have resulted and are continuing to result in significant monetary damages to Gilat and its shareholders, and are expected to amount to hundreds of millions of dollars if the merger is not consummated," Gilat added. "While Gilat has not interfered or taken any action to interfere with Comtech's pending application with the Russian Federal Anti-Monopoly Service or otherwise breached the Merger Agreement, Gilat believes that Comtech has willfully breached its obligations under the Merger Agreement so as to attempt to ensure that FAS approval is not timely obtained and Comtech will not be required to consummate the merger. Gilat intends to vigorously defend its position in connection with the claims raised by Comtech and all related matters." Gilat also intends to file a counter claim against Comtech seeking, among other things, a declaration that Comtech cannot terminate the Merger Agreement and, if the merger is not consummated, Comtech should pay Gilat monetary damages "for all losses that Gilat and its shareholders and option holders have suffered as a result of Comtech's willful breaches of the Merger Agreement, which Gilat will assert amount to hundreds of millions of dollars."

ShowHide Related Items >><<
GILT Gilat Satellite
$5.10 /

-0.01 (-0.20%)

GILT Gilat Satellite
$5.10 /

-0.01 (-0.20%)

GILT Gilat Satellite
$5.10 /

-0.01 (-0.20%)

GILT Gilat Satellite
$5.10 /

-0.01 (-0.20%)

On The Fly
Opening Day: Cancer 'killer' Nkarta soars after coming public » 08:57
07/12/20
07/12
08:57
07/12/20
08:57
BLCT

BlueCity

$24.39 /

-1.59 (-6.12%)

, NKTX

Nkarta

$47.46 /

+ (+0.00%)

, QH

Quhuo

$12.62 /

+ (+0.00%)

, PSTX

Poseida Therapeutics

$15.60 /

+ (+0.00%)

, RXT

Rackspace Technology

$0.00 /

+ (+0.00%)

, NCNO

nCino

$0.00 /

+ (+0.00%)

, GOCO

GoHealth

$0.00 /

+ (+0.00%)

China's biggest gay…

Open Full Text

ShowHide Related Items >><<
  • 15
    Jul
  • 15
    Jul
  • 08
    Jul
  • 10
    Jul
  • 10
    Jul
RXT Rackspace Technology
$0.00 /

+ (+0.00%)

NKTX Nkarta
$47.46 /

+ (+0.00%)

Conference/Events
Society for Pediatric Dermatology to hold virtual meeting » 05:55
07/12/20
07/12
05:55
07/12/20
05:55
ABEO

Abeona Therapeutics

$3.01 /

-0.34 (-10.15%)

, AMGN

Amgen

$249.23 /

-2.03 (-0.81%)

, DRMT

Dermavant

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.02 /

-0.3 (-0.34%)

, PFE

Pfizer

$33.84 /

+0.39 (+1.17%)

, SNY

Sanofi

$50.32 /

-0.24 (-0.47%)

, VRCA

Verrica Pharmaceuticals

$9.51 /

+0.75 (+8.56%)

45th Annual Virtual…

45th Annual Virtual Meeting: SPD2020 will be held on July 10-12. Webcast Link

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

DRMT Dermavant
$0.00 /

+ (+0.00%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

06/05/20 Cantor Fitzgerald
Abeona could trade higher on Lysogene clinical hold, says Cantor Fitzgerald
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
AMGN Amgen
$249.23 /

-2.03 (-0.81%)

07/02/20 Citi
Citi sees 'considerable amount of investor interest' coming back to Amgen
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Mizuho
Amgen patent win worth $5-$12 per share, says Mizuho
07/01/20 Goldman Sachs
Court ruling removes overhang for Amgen, says Goldman Sachs
DRMT Dermavant
$0.00 /

+ (+0.00%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$33.84 /

+0.39 (+1.17%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
SNY Sanofi
$50.32 /

-0.24 (-0.47%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
03/24/20 Needham
Verrica Pharmaceuticals initiated with a Buy at Needham
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

  • 20
    Dec
SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

Periodicals
ASML powering past pandemic, Barron's says » 09:47
07/11/20
07/11
09:47
07/11/20
09:47
ASML

ASML

$396.30 /

+1.605 (+0.41%)

ASML a leading…

ASML a leading manufacturer of lithography machines used by major semiconductor makers to print ever-denser circuits, but the company issued a profit warning at the end of March, after completion of the installation of new equipment around the world was delayed by the pandemic, with demand for chips in cars also plunging and ASML then cutting first-quarter guidance, Rupert Steiner writes in his week's edition of Barron's. However, shares have since bounced back on strong demand, as sheltering-at-home workers turned to the cloud for storage and bought chip-intensive laptops, the author notes, adding that the stock could still rise further. Reference Link

ShowHide Related Items >><<
ASML ASML
$396.30 /

+1.605 (+0.41%)

ASML ASML
$396.30 /

+1.605 (+0.41%)

07/10/20 JPMorgan
ASML price target raised to EUR 408 from EUR 280 at JPMorgan
07/10/20 Morgan Stanley
ASML price target raised to EUR 380 from EUR 275 at Morgan Stanley
07/09/20 Wells Fargo
ASML price target raised to $430 from $410 at Wells Fargo
06/17/20 Evercore ISI
ASML price target raised to EUR 375 from EUR 325 at Evercore ISI
ASML ASML
$396.30 /

+1.605 (+0.41%)

ASML ASML
$396.30 /

+1.605 (+0.41%)

ASML ASML
$396.30 /

+1.605 (+0.41%)

Periodicals
Facebook stock remains resilient amid controversy, Barron's says » 09:44
07/11/20
07/11
09:44
07/11/20
09:44
SBUX

Starbucks

$74.29 /

+0.69 (+0.94%)

, UL

Unilever

$54.23 /

+0.535 (+1.00%)

, KO

Coca-Cola

$45.15 /

+1.23 (+2.80%)

, FB

Facebook

$245.01 /

+0.35 (+0.14%)

In the wake of…

In the wake of Facebook's (FB) first big scandal in 2018, Barron's labeled the company a sin stock - controversial but still full of upside, and now Facebook finds itself in the middle of a global boycott from 1,000 advertisers, brought to task by a coalition of civil-rights groups that cite hate speech and voter suppression that appear on its platform, Max Cherney writes in this week's edition of Barron's. While most stocks would crater under that kind of pressure, Facebook is well insulated from advertiser defections, even with big brands like Coca-Cola (KO), Unilever (UL) and Starbucks (SBUX) pausing their spending given its 8M customers, mostly small and medium-sized businesses buying adds, the author notes. Reference Link

ShowHide Related Items >><<
UL Unilever
$54.23 /

+0.535 (+1.00%)

SBUX Starbucks
$74.29 /

+0.69 (+0.94%)

KO Coca-Cola
$45.15 /

+1.23 (+2.80%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

SBUX Starbucks
$74.29 /

+0.69 (+0.94%)

06/24/20 JPMorgan
Starbucks price target raised to $78 from $73 at JPMorgan
06/15/20
Fly Intel: Top five analyst initiations
06/15/20 Atlantic Equities
Starbucks initiated with an Overweight at Atlantic Equities
06/11/20
Fly Intel: Top five analyst downgrades
UL Unilever
$54.23 /

+0.535 (+1.00%)

07/07/20 Bryan Garnier
Unilever downgraded to Neutral from Buy at Bryan Garnier
07/06/20 RBC Capital
Unilever price target raised to EUR 34 from EUR 33 at RBC Capital
06/29/20 Barclays
Unilever price target raised to EUR 43.70 from EUR 43.10 at Barclays
06/29/20
Fly Intel: Top five analyst downgrades
KO Coca-Cola
$45.15 /

+1.23 (+2.80%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
05/28/20 Credit Suisse
Boston Beer downgraded to Neutral on valuation at Credit Suisse
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/11/20 Citi
Monster Beverage downgraded to Neutral from Buy at Cit
FB Facebook
$245.01 /

+0.35 (+0.14%)

07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
07/01/20 Monness Crespi
Facebook has opportunity to emerge from crisis stronger, says Monness Crespi
07/01/20 Goldman Sachs
Facebook checks show limited impact from ad boycott, says Goldman Sachs
SBUX Starbucks
$74.29 /

+0.69 (+0.94%)

KO Coca-Cola
$45.15 /

+1.23 (+2.80%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

UL Unilever
$54.23 /

+0.535 (+1.00%)

SBUX Starbucks
$74.29 /

+0.69 (+0.94%)

KO Coca-Cola
$45.15 /

+1.23 (+2.80%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

UL Unilever
$54.23 /

+0.535 (+1.00%)

SBUX Starbucks
$74.29 /

+0.69 (+0.94%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

SBUX Starbucks
$74.29 /

+0.69 (+0.94%)

KO Coca-Cola
$45.15 /

+1.23 (+2.80%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

Periodicals
Nordstrom may be worth the wait, Barron's says » 09:27
07/11/20
07/11
09:27
07/11/20
09:27
JWN

Nordstrom

$15.75 /

+0.46 (+3.01%)

, REAL

RealReal

$13.77 /

-0.51 (-3.57%)

, YETI

Yeti

$41.79 /

-0.08 (-0.19%)

, NKE

Nike

$97.98 /

+0.98 (+1.01%)

, LULU

Lululemon

$314.47 /

+0.02 (+0.01%)

Retail sales plunged in…

Retail sales plunged in March and April, and though sales have been rebounding-May saw the largest month-over-month increase in retail sales on record-retailers can't depend on pent-up demand and store reopenings to keep sales rising, Teresa Rivas writes in this week's edition of Barron's. Lululemon (LULU) and Nike (NKE) have been among the most prominent retailers to negotiate that transition, but they are not alone, the author notes. Yeti (YETI) is one of those, with its strategy paying off and shares rising 38% during the first quarter. The RealReal (REAL) hasn't performed nearly as well as Yeti, but the company's online consultations for its customers simulating an in-store experience could be beneficial from a cost and time perspective, the publication adds. While Nordstrom (JWN) looks even worse off than RealReal, its earnings per share have fallen less than its peers over the part year and it could eventually be worth the wait for those with patience, Rivas contends. Reference Link

ShowHide Related Items >><<
YETI Yeti
$41.79 /

-0.08 (-0.19%)

REAL RealReal
$13.77 /

-0.51 (-3.57%)

NKE Nike
$97.98 /

+0.98 (+1.01%)

LULU Lululemon
$314.47 /

+0.02 (+0.01%)

JWN Nordstrom
$15.75 /

+0.46 (+3.01%)

JWN Nordstrom
$15.75 /

+0.46 (+3.01%)

05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/07/20 Deutsche Bank
Nordstrom price target lowered to $18 from $35 at Deutsche Bank
04/30/20 Wedbush
Nordstrom price target lowered to $20 from $36 at Wedbush
03/27/20 Cleveland Research
Nordstrom downgraded at Cleveland Research, says QTD net sales have slowed
REAL RealReal
$13.77 /

-0.51 (-3.57%)

07/10/20 B. Riley FBR
RealReal price target raised to $13 from $7 at B. Riley FBR
06/10/20 Nomura Instinet
RealReal price target raised to $18 from $17 at Nomura Instinet
06/09/20
Fly Intel: Top five analyst initiations
06/09/20 Nomura Instinet
RealReal price target raised to $17 from $14 at Nomura Instinet
YETI Yeti
$41.79 /

-0.08 (-0.19%)

07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Goldman Sachs
Yeti downgraded to Neutral from Buy at Goldman Sachs
06/23/20 Piper Sandler
Yeti price target raised to $47 from $35 at Piper Sandler
06/10/20 Cowen
Yeti price target raised to $41 from $31 at Cowen
NKE Nike
$97.98 /

+0.98 (+1.01%)

06/26/20 Morgan Stanley
Market understands Nike's near-term challenges, says Morgan Stanley
06/26/20 Credit Suisse
Nike price target lowered to $111 from $114 at Credit Suisse
06/26/20 UBS
Nike price target raised to $127 from $122 at UBS
06/26/20 Citi
Nike disappointments offset by quarter-to-date performance, says Citi
LULU Lululemon
$314.47 /

+0.02 (+0.01%)

07/09/20 Barclays
'Surprise' Lululemon sale may pressure shares, says Barclays
07/09/20 Barclays
Lululemon started warehouse sale online today, says Barclays
06/30/20 Morgan Stanley
Lululemon boosted competitive advantage with Mirror deal, says Morgan Stanley
06/30/20 MKM Partners
Lululemon's Mirror deal 'highly attractive and synergistic', says MKM Partners
YETI Yeti
$41.79 /

-0.08 (-0.19%)

REAL RealReal
$13.77 /

-0.51 (-3.57%)

NKE Nike
$97.98 /

+0.98 (+1.01%)

LULU Lululemon
$314.47 /

+0.02 (+0.01%)

JWN Nordstrom
$15.75 /

+0.46 (+3.01%)

  • 28
    May
  • 11
    May
  • 17
    Feb
  • 13
    Dec
  • 07
    Nov
YETI Yeti
$41.79 /

-0.08 (-0.19%)

NKE Nike
$97.98 /

+0.98 (+1.01%)

LULU Lululemon
$314.47 /

+0.02 (+0.01%)

JWN Nordstrom
$15.75 /

+0.46 (+3.01%)

YETI Yeti
$41.79 /

-0.08 (-0.19%)

REAL RealReal
$13.77 /

-0.51 (-3.57%)

NKE Nike
$97.98 /

+0.98 (+1.01%)

LULU Lululemon
$314.47 /

+0.02 (+0.01%)

JWN Nordstrom
$15.75 /

+0.46 (+3.01%)

REAL RealReal
$13.77 /

-0.51 (-3.57%)

NKE Nike
$97.98 /

+0.98 (+1.01%)

LULU Lululemon
$314.47 /

+0.02 (+0.01%)

JWN Nordstrom
$15.75 /

+0.46 (+3.01%)

Periodicals
Nokia to gain from 5G spending, stock still 'cheap,' Barron's says » 09:18
07/11/20
07/11
09:18
07/11/20
09:18
ERIC

Ericsson

$9.42 /

+0.045 (+0.48%)

, NOK

Nokia

$4.13 /

-0.045 (-1.08%)

Once the most valuable…

Once the most valuable European stock, with a market cap that touched $300B, shares of Nokia (NOK) have fallen more than 90% since 2000, to $24B, Eric Savitz writes in this week's edition of Barron's. Yet there are reasons to think the worst is over given the speedy wireless standard known as 5G and as the company finds itself in favor with the Trump administration, which has expressed interest in bolstering both Nokia and Ericsson (ERIC) in their competition against Huawei, the author notes. Reference Link

ShowHide Related Items >><<
NOK Nokia
$4.13 /

-0.045 (-1.08%)

ERIC Ericsson
$9.42 /

+0.045 (+0.48%)

ERIC Ericsson
$9.42 /

+0.045 (+0.48%)

04/17/20 Credit Suisse
Ericsson price target raised to SEK 98 from SEK 97 at Credit Suisse
03/30/20 BofA
US 1 List changes at BofA
03/30/20 Cowen
Ericsson upgraded to Outperform from Market Perform at Cowen
03/27/20 Raymond James
Raymond James upgrades Ericsson with networking an essential service
NOK Nokia
$4.13 /

-0.045 (-1.08%)

07/08/20 JPMorgan
Nokia downgraded to Neutral from Overweight at JPMorgan
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Deutsche Bank
Nokia price target raised to EUR 4.80 from EUR 4 at Deutsche Bank
06/01/20 JPMorgan
JPMorgan upgrades Nokia to Overweight with 5G cycle 'just starting'
NOK Nokia
$4.13 /

-0.045 (-1.08%)

ERIC Ericsson
$9.42 /

+0.045 (+0.48%)

NOK Nokia
$4.13 /

-0.045 (-1.08%)

ERIC Ericsson
$9.42 /

+0.045 (+0.48%)

NOK Nokia
$4.13 /

-0.045 (-1.08%)

ERIC Ericsson
$9.42 /

+0.045 (+0.48%)

NOK Nokia
$4.13 /

-0.045 (-1.08%)

ERIC Ericsson
$9.42 /

+0.045 (+0.48%)

On The Fly
Week in review: How Trump's policies moved stocks » 08:47
07/11/20
07/11
08:47
07/11/20
08:47
ZTCOY

ZTE Corp.

$0.00 /

+ (+0.00%)

, WDC

Western Digital

$42.31 /

-0.03 (-0.07%)

, MU

Micron

$50.70 /

+0.71 (+1.42%)

, ACIA

Acacia Communications

$67.83 /

+0.01 (+0.01%)

, NPTN

NeoPhotonics

$9.01 /

+0.2 (+2.27%)

, LITE

Lumentum

$82.44 /

-1.49 (-1.78%)

, IIVI

II-VI

$44.55 /

+0.18 (+0.41%)

, SNAP

Snap

$25.53 /

-0.41 (-1.58%)

, AMZN

Amazon.com

$3,204.06 /

+19.57 (+0.61%)

, TWTR

Twitter

$35.40 /

-0.3 (-0.84%)

, FNMA

Fannie Mae

$0.00 /

+ (+0.00%)

, FMCC

Freddie Mac

$0.00 /

+ (+0.00%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
ZTCOY ZTE Corp.
$0.00 /

+ (+0.00%)

WDC Western Digital
$42.31 /

-0.03 (-0.07%)

TWTR Twitter
$35.40 /

-0.3 (-0.84%)

SNAP Snap
$25.53 /

-0.41 (-1.58%)

NPTN NeoPhotonics
$9.01 /

+0.2 (+2.27%)

MU Micron
$50.70 /

+0.71 (+1.42%)

LITE Lumentum
$82.44 /

-1.49 (-1.78%)

IIVI II-VI
$44.55 /

+0.18 (+0.41%)

FNMA Fannie Mae
$0.00 /

+ (+0.00%)

FMCC Freddie Mac
$0.00 /

+ (+0.00%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

ACIA Acacia Communications
$67.83 /

+0.01 (+0.01%)

ZTCOY ZTE Corp.
$0.00 /

+ (+0.00%)

07/02/20 Roth Capital
USF ban for Huawei, ZTE should benefit Cambium, says Roth Capital
02/18/20 Goldman Sachs
ZTE Corp. downgraded to Neutral from Buy at Goldman Sachs
12/03/19 Rosenblatt
Lumentum, Maxim, Macom to benefit from ZTE, Huawei procurement, says Rosenblatt
11/05/19 Rosenblatt
Applied Optoelectronics upgraded to Buy ahead of guidance at Rosenblatt
WDC Western Digital
$42.31 /

-0.03 (-0.07%)

06/30/20 Benchmark
Micron report and guidance 'bode well' for Western Digital, says Benchmark
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/22/20 Benchmark
Western Digital upgraded to Buy from Hold at Benchmark
06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
MU Micron
$50.70 /

+0.71 (+1.42%)

06/30/20 RBC Capital
Micron price target raised to $60 from $55 at RBC Capital
06/30/20 Morgan Stanley
Morgan Stanley would add to Micron positions on weakness in coming 'rough patch'
06/30/20 Raymond James
Micron price target raised to $65 from $60 at Raymond James
06/30/20 Mizuho
Micron price target raised to $63 from $60 at Mizuho
ACIA Acacia Communications
$67.83 /

+0.01 (+0.01%)

09/23/19 Northland
Inphi drops after Northland sees 'large cut' to Amazon 400G rollout plans
07/18/19 JPMorgan
JPMorgan boosts Ciena target to $53, sees further share upside
07/16/19 Rosenblatt
Acacia Communications downgraded to Neutral from Buy at Rosenblatt
NPTN NeoPhotonics
$9.01 /

+0.2 (+2.27%)

06/16/20 B. Riley FBR
NeoPhotonics downgraded to Neutral on Huawei risks at B. Riley FBR
06/16/20 B. Riley FBR
NeoPhotonics downgraded to Neutral from Buy at B. Riley FBR
05/21/20 Rosenblatt
Rosenblatt sees little impact on Lumentum, NeoPhotonics' current sales to Huawei
05/01/20 Northland
NeoPhotonics price target raised to $13 from $9.75 at Northland
LITE Lumentum
$82.44 /

-1.49 (-1.78%)

07/02/20 MKM Partners
Lumentum price target raised to $107 from $96 at MKM Partners
05/06/20 Craig-Hallum
Lumentum price target raised to $100 from $95 at Craig-Hallum
05/06/20 Piper Sandler
Lumentum price target raised to $100 from $95 at Piper Sandler
IIVI II-VI
$44.55 /

+0.18 (+0.41%)

07/06/20 JPMorgan
II-VI shares offer 25% upside potential, says JPMorgan
07/01/20 Susquehanna
II-VI price target raised to $54 from $50 at Susquehanna
06/09/20 Needham
II-VI price target raised to $57 from $52 at Needham
05/12/20 Deutsche Bank
II-VI price target raised to $50 from $35 at Deutsche Bank
SNAP Snap
$25.53 /

-0.41 (-1.58%)

07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
06/29/20 JPMorgan
Facebook estimates not at risk from ad boycott, says JPMorgan
06/26/20 Wells Fargo
Snap price target raised to $28 from $20 at Wells Fargo
06/25/20 Citi
Citi recommends pair trade of buying Omnicom, selling Snap
AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

07/10/20 Citi
Amazon.com price target raised to $3,550 from $2,700 at Citi
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/09/20 Credit Suisse
Consumer survey highlights good initial interest in Walmart+, says Credit Suisse
07/08/20 Morgan Stanley
Walmart membership plan seems geared at protecting grocery, says Morgan Stanley
TWTR Twitter
$35.40 /

-0.3 (-0.84%)

07/10/20 Morgan Stanley
Morgan Stanley says Twitter subscription would need to be $50/year for breakeven
07/09/20 JPMorgan
JPMorgan 'somewhat skeptical' of Twitter subscription service
07/09/20 Citi
Twitter shares overreacted to paid service potential, says Citi
07/08/20 Rosenblatt
Rosenblatt says 'highly unlikely' Twitter considering paid subscription tiers
FNMA Fannie Mae
$0.00 /

+ (+0.00%)

07/09/20 Odeon Capital
Fannie Mae upgraded to Hold from Sell at Odeon Capital
04/22/20 Nomura Instinet
Fannie, Freddie well positioned for recession, says Nomura Instinet
04/06/20 B. Riley FBR
Fannie, Freddie downgraded to Sell with $1 targets at B. Riley FBR
04/06/20 B. Riley FBR
Fannie Mae downgraded to Sell from Neutral at B. Riley FBR
FMCC Freddie Mac
$0.00 /

+ (+0.00%)

07/09/20 Odeon Capital
Freddie Mac upgraded to Hold from Sell at Odeon Capital
06/04/20 Nomura Instinet
Nomura boosts Freddie Mac target to $5, sees dividends after Q3 of 2024
05/01/20 B. Riley FBR
B. Riley FBR keeps $1 target on Freddie Mac after Q1 earnings miss
WDC Western Digital
$42.31 /

-0.03 (-0.07%)

TWTR Twitter
$35.40 /

-0.3 (-0.84%)

SNAP Snap
$25.53 /

-0.41 (-1.58%)

NPTN NeoPhotonics
$9.01 /

+0.2 (+2.27%)

MU Micron
$50.70 /

+0.71 (+1.42%)

LITE Lumentum
$82.44 /

-1.49 (-1.78%)

IIVI II-VI
$44.55 /

+0.18 (+0.41%)

FNMA Fannie Mae
$0.00 /

+ (+0.00%)

FMCC Freddie Mac
$0.00 /

+ (+0.00%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

ACIA Acacia Communications
$67.83 /

+0.01 (+0.01%)

  • 02
    Jul
ZTCOY ZTE Corp.
$0.00 /

+ (+0.00%)

WDC Western Digital
$42.31 /

-0.03 (-0.07%)

TWTR Twitter
$35.40 /

-0.3 (-0.84%)

SNAP Snap
$25.53 /

-0.41 (-1.58%)

MU Micron
$50.70 /

+0.71 (+1.42%)

FNMA Fannie Mae
$0.00 /

+ (+0.00%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

ZTCOY ZTE Corp.
$0.00 /

+ (+0.00%)

WDC Western Digital
$42.31 /

-0.03 (-0.07%)

TWTR Twitter
$35.40 /

-0.3 (-0.84%)

SNAP Snap
$25.53 /

-0.41 (-1.58%)

NPTN NeoPhotonics
$9.01 /

+0.2 (+2.27%)

MU Micron
$50.70 /

+0.71 (+1.42%)

LITE Lumentum
$82.44 /

-1.49 (-1.78%)

IIVI II-VI
$44.55 /

+0.18 (+0.41%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

ACIA Acacia Communications
$67.83 /

+0.01 (+0.01%)

WDC Western Digital
$42.31 /

-0.03 (-0.07%)

TWTR Twitter
$35.40 /

-0.3 (-0.84%)

SNAP Snap
$25.53 /

-0.41 (-1.58%)

MU Micron
$50.70 /

+0.71 (+1.42%)

LITE Lumentum
$82.44 /

-1.49 (-1.78%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

Conference/Events
Society for Pediatric Dermatology to hold virtual meeting » 04:55
07/11/20
07/11
04:55
07/11/20
04:55
ABEO

Abeona Therapeutics

$3.01 /

-0.34 (-10.15%)

, AMGN

Amgen

$249.23 /

-2.03 (-0.81%)

, DRMT

Dermavant

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.02 /

-0.3 (-0.34%)

, PFE

Pfizer

$33.84 /

+0.39 (+1.17%)

, SNY

Sanofi

$50.32 /

-0.24 (-0.47%)

, VRCA

Verrica Pharmaceuticals

$9.51 /

+0.75 (+8.56%)

45th Annual Virtual…

45th Annual Virtual Meeting: SPD2020 will be held on July 10-12. Webcast Link

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

DRMT Dermavant
$0.00 /

+ (+0.00%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

06/05/20 Cantor Fitzgerald
Abeona could trade higher on Lysogene clinical hold, says Cantor Fitzgerald
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
AMGN Amgen
$249.23 /

-2.03 (-0.81%)

07/02/20 Citi
Citi sees 'considerable amount of investor interest' coming back to Amgen
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Mizuho
Amgen patent win worth $5-$12 per share, says Mizuho
07/01/20 Goldman Sachs
Court ruling removes overhang for Amgen, says Goldman Sachs
DRMT Dermavant
$0.00 /

+ (+0.00%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$33.84 /

+0.39 (+1.17%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
SNY Sanofi
$50.32 /

-0.24 (-0.47%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
03/24/20 Needham
Verrica Pharmaceuticals initiated with a Buy at Needham
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

  • 20
    Dec
SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

Periodicals
Exxon Mobil resumes drilling in Guyana, Bloomberg reports » 18:51
07/10/20
07/10
18:51
07/10/20
18:51
XOM

Exxon Mobil

$42.66 /

+1.315 (+3.18%)

, BKR

Baker Hughes

$15.06 /

+0.41 (+2.80%)

Exxon Mobil (XOM) resumed…

Exxon Mobil (XOM) resumed drilling in Guyana in June, underscoring its dedication to the area despite the oil price crash and a messy turn in local politics, Bloomberg's Peter Millard and Kevin Crowley report. Two of Exxon's four drillships went back to work, according to data published Friday by Baker Hughes (BKR). The company later confirmed that the Stena Carron and Noble Tom Madden vessels returned to full operations last month. The rigs had been shut when Guyana closed its borders after the pandemic hit South America. Reference Link

ShowHide Related Items >><<
XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
05/13/20 Redburn
Exxon Mobil upgraded to Neutral from Sell at Redburn
05/04/20 Credit Suisse
Exxon Mobil price target raised to $45 from $37 at Credit Suisse
BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

05/29/20 Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

Periodicals
Atlanta Mayor to pull COVID-19 reopening back to phase 1, CNBC reports » 17:45
07/10/20
07/10
17:45
07/10/20
17:45
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.65 /

+3.22 (+1.02%)

In Atlanta, Phase 1…

In Atlanta, Phase 1 involvings staying at home, with essential travel only, according to CNBC.

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Boeing scrambling to gather financing for 737 MAX, Reuters says » 17:44
07/10/20
07/10
17:44
07/10/20
17:44
BA

Boeing

$178.45 /

+5.225 (+3.02%)

Boeing is scrambling to…

Boeing is scrambling to gather financing for the 737 MAX as it awaits regulatory clearance for design changes after the aircraft was grounded following two deadly crashes, Reuters' Tracy Rucinski and Tim Hepher report, citing industry sources. Boeing is seeking to resume deliveries once regulators say it is safe and airlines agree on training, but confidence in the 737 MAX has been harmed by the grounding, making the financing required to ensure smooth deliveries scarce and compounding a lack in demand due to the COVID-19 pandemic, the authors note. "Nobody wants to take new aircraft and this is particularly true for the MAX right now," a senior aviation financier said, according to Reuters. Reference Link

ShowHide Related Items >><<
BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

Hot Stocks
Harte-Hanks announces suspension of trading, commences delisting procedures » 17:42
07/10/20
07/10
17:42
07/10/20
17:42
HHS

Harte-Hanks

$2.75 /

-0.22 (-7.41%)

Harte Hanks announced the…

Harte Hanks announced the company was notified by the NYSE on July 9 that the NYSE had determined to commence proceedings to delist the company's common stock as a result of the company's failure to comply with the continued listing standard to maintain either (i) at least $50M in stockholders' equity or (ii) at least $50M in total market capitalization on a 30-trading day average basis. While the company has the ability to appeal the decision by the NYSE, Harte Hanks' board has determined that it is in the best interest of the company and its shareholders to immediately begin trading on the OTCQX Best Market. The company will remain subject to the public reporting requirements of the SEC following the transfer to the OTCQX and expects the common stock will trade under the symbol "HRTE". The transition to the over-the-counter markets will not affect the company's business operations.

ShowHide Related Items >><<
HHS Harte-Hanks
$2.75 /

-0.22 (-7.41%)

Hot Stocks
Tesla says 2020 annual meeting holders may also attend Battery Day presentation » 17:39
07/10/20
07/10
17:39
07/10/20
17:39
TSLA

Tesla

$1,547.54 /

+153.99 (+11.05%)

Tesla announced that its…

Tesla announced that its 2020 Annual Meeting of Stockholders will be held in person on Tuesday, September 22, 2020, at 2:30 p.m. Pacific Time, at Tesla's Fremont Factory located at 45500 Fremont Blvd, Fremont, CA 94538. Eligible stockholders may also attend Tesla's separate Battery Day presentation, which will be held on the same day, with additional details to be announced at a later time. No formal stockholder business will be conducted at such presentation. Tesla intends to webcast both events live.

ShowHide Related Items >><<
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

07/09/20 Wedbush
China growth story worth $400/share in a bull case to Tesla, says Wedbush
07/07/20 Morgan Stanley
Morgan Stanley raises Tesla price target to $740 with new bull case of $2,070
07/07/20 Barclays
Tesla bears should 'remain in the shelter,' says Barclays
07/06/20 JMP Securities
Tesla price target raised to $1,500 from $1,050 at JMP Securities
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

  • 14
    Feb
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

Hot Stocks
W&T Offshore CEO buys 346K shares of common stock » 17:33
07/10/20
07/10
17:33
07/10/20
17:33
WTI

W&T Offshore

$2.31 /

+0.155 (+7.21%)

In a regulatory filing,…

In a regulatory filing, W&T Offshore disclosed that its CEO Tracy Krohn bought 346,358 shares of common stock on July 8th in a transaction total of $740K.

ShowHide Related Items >><<
WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

04/17/20 Roth Capital
W&T Offshore upgraded to Buy from Neutral at Roth Capital
03/13/20 Roth Capital
W&T Offshore downgraded to Neutral from Buy at Roth Capital
03/09/20 Stifel
W&T Offshore downgraded to Hold from Buy at Stifel
WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.